![]() |
Advanced Search |
Central Nervous System (CNS) StudiesGain a competitive edge with the depth and breadth of PPD’s expertise in central nervous system (CNS) drug and device studies, including psychiatric and neurological indications and chronic pain. Our global operations team develops the best strategies to conduct studies and navigate the regulatory process. PPD optimizes efficiencies with:
Effective Management of Complex Studies With expertise in more than 35 different psychiatric and neurological disorders, our clinically trained CNS teams are led by senior scientists and clinicians with extensive CNS development experience. Global Investigator Network Our global investigator network includes more than 2,600 psychiatrists, neurologists, neurological surgeons and gerontologists with demonstrated experience in a variety of clinical trial models. Our trial capabilities are supported by well-established relationships with university and state hospitals, Veterans Affairs medical centers and private inpatient facilities. CNS Consultants Our CNS consultants are closely involved in the education of our project teams, advising on protocol feasibility and consulting to our clients. Device Development Expertise in CNS PPD Medical Device, a division of PPD, has specialized expertise in device development, finding solutions for nervous system disorders and helping to improve quality of life regarding pain management and cessation. Our experience includes:
Study Experience (2002-2006) We have strategic development planning and program management expertise for 29 CNS products, many of them global studies: Psychiatric indications
Neurological indications
Pain studies
Special populations
* More than 16 years’ experience at our PPD dental research clinic |
|
||||||
|
|||||